Indeed, Bense et al. observed that a higher fraction of γδ T-cells, a lesser known type of CD8+ T-cell, correlated positively with improved overall survival in all breast cancer subtypes, including HER2+ breast cancer patients [226]. The gene discussed is ERBB2; the disease is breast cancer.